Medical technology company receives financing to introduce BreastScanIR.

2004 NOV 4 - (NewsRx.com & NewsRx.net) -- Infrared Sciences Corporation (ISC) announced that it has completed a $1 million series A preferred stock financing, acquiring the capital necessary to introduce BreastScan IR to a broader market of doctors and patients.

Utilizing infrared imaging and proprietary software, BreastScan IR is designed to be used as an adjunctive test with mammography, ultrasound or clinical examination for the early detection of breast cancer.

"BreastScan IR unleashes the tremendous potential of infrared imaging as an accurate, easy-to-use early detection technology," explained ISC president Tom DiCicco.

DiCicco continued, "By introducing fully-automated computer analysis that greatly increases the effectiveness and repeatability of the technology in helping to determine breast health, BreastScan IR is light-years beyond any previous infrared imaging system. It is the only system in the world that allows any doctor ready access to this valuable technology, regardless of their individual expertise in infrared imaging. The "expert" is in the computer program."

ISC is now qualifying requests from doctors across America who can use BreastScan IR effectively a minimum of 200 times a month. ISC will provide BreastScan IR systems to qualified doctors at no up-front cost, and receives only a small fee each time the system is used. Each doctor determines the fee to be charged to patients for the procedure.

"With the costs of a single BreastScan IR system console approaching $75,000, providing them to doctors on strictly a pay-per-use basis is a significant up-front commitment for us," continued DiCicco. "Receiving this second round of funding is a major step in helping us bring BreastScan IR to market - and a tremendous opportunity for doctors to provide the benefits of BreastScan IR to the largest number of women as quickly as possible."

BreastScan IR is a painless, noninvasive procedure that measures infrared emissions from the breast, and compares them with established parameters in the system's neural network computer software. BreastScan IR is unique among breast health evaluation tests in that it provides the doctor with physiological breast data, which can provide very early, indirect indications of areas of concern, as well as pinpointing the exact location of anomalies.